Cardiff Oncology Secures $13.5 Million Equity Investment from Biotech-Focused Fundamental Institutional Investors Acorn Bioventures and CAM Capital

SAN DIEGO, June 16, 2020 -- (Healthcare Sales & Marketing Network) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology therapeutics company developing drugs to treat cancers with the greatest medical need for new treatment options, includi... Biopharmaceuticals, Oncology, Venture Capital Cardiff Oncology, Onvansertib, Colorectal Cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news